Additionally, as a surface protein, DPP4 serves as a promising target for DPP4-specific antibodies, enabling selective elimination of senescent cells [24]
BPC-157: Discovery and Regulatory History BPC-157 is a synthetic pentadecapeptide whose documented history begins with Croatian gastric-physiology research in the early 1990s and extends, through a Pliva-sponsored clinical program and a large preclinical literature, to the anti-doping monitoring status it holds today
After NSAIDs or insulin overdose or cuprizone (a neurotoxin that induces multiple sclerosis like lesion in rat model) or large bowel resection, encephalopathies were attenuated along with gastrointestinal, liver and vascular injuries
Retatrutide's evidence base is more substantial but still in development
Plan for integration, not duplication Can you convert existing GAC to BAC
rotate injection sites systematically